HIPEC surgery plus chemotherapy for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether a specialized surgery called HIPEC (heat-treated chemotherapy placed in the belly) can improve outcomes for people with advanced stomach cancer that has reached the lining of the abdomen. It’s given after you’ve already had standard chemotherapy, aiming to better control disease in the belly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have confirmed stomach cancer that involves the lining of the abdomen (peritoneum) and/or positive peritoneal fluid tests.
- You have finished prior chemotherapy for your cancer, and it has been at least about 2–4 months since then.
- Your health status is good enough for treatment (you can usually care for yourself; “ECOG 0–2” or similar).
- Your blood and organ tests meet safety thresholds (enough white blood cells and platelets, and acceptable liver/kidney function).
- You must not have spread to organs like liver, lungs, bone, or brain—spread is limited to nearby lymph nodes and the peritoneum.
- You can use reliable birth control (and avoid pregnancy and breastfeeding during treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines heated chemotherapy directly into the abdomen (HIPEC) with standard chemotherapy and an immunotherapy drug to treat advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests a combination of chemotherapy drugs given before surgery to shrink advanced stomach cancer tumors and improve outcomes. It may help patients with stage T3/4 or node-positive stomach cancer who have not had prior treatment for their cancer.
This Phase 3 trial studies whether adding a heated chemotherapy procedure during surgery (HIPEC) before the main cancer treatment can lower the chance that stomach cancer returns in the belly. It is for people with advanced stomach cancer who are at higher risk of cancer coming back in the peritoneum (the lining of the abdomen).
This trial compares standard laparoscopic surgery for stomach cancer versus the same surgery plus HIPEC, which is heated chemotherapy placed in the abdomen during the operation. It aims to see if adding the heated chemotherapy improves outcomes for people with higher-stage stomach cancer.
This trial studies a combination treatment for stomach cancer that has spread to the lining of the abdomen. It uses a special way to deliver heated chemotherapy directly into the abdomen, along with an immunotherapy drug that helps your immune system attack the cancer.
This study tests whether a thorough surgery to remove stomach cancer in the abdomen, followed by chemotherapy given through the belly and by vein, can improve outcomes. It’s for people newly diagnosed with stomach cancer that has limited spread to the belly lining.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.